Table 3 Cox regression analysis... | American Society of Hematology

Table 3

Cox regression analysis

Covariate	Univariate		Multivariate
Covariate	Hazard ratio (95% CI)	P	Hazard ratio (95% CI)	P
RFC80 AA versus GA/GG	0.50 (0.25-1.00)	.046	0.56 (0.28-1.13)	.10†
Phenotype, pre B versus T*	0.97 (0.51-1.87)	.94		.94‡
Copy no. of Chr21 higher than 2 versus 2	0.80 (0.46-1.39)	.44		.71‡
Risk group, high versus low	2.97 (1.90-4.63)	< .001	2.86 (1.83-4.47)	< .001
Protocol, 2000 versus 1992	0.90 (0.55-1.48)	.68		.32‡

Covariate	Univariate		Multivariate
Covariate	Hazard ratio (95% CI)	P	Hazard ratio (95% CI)	P
RFC80 AA versus GA/GG	0.50 (0.25-1.00)	.046	0.56 (0.28-1.13)	.10†
Phenotype, pre B versus T*	0.97 (0.51-1.87)	.94		.94‡
Copy no. of Chr21 higher than 2 versus 2	0.80 (0.46-1.39)	.44		.71‡
Risk group, high versus low	2.97 (1.90-4.63)	< .001	2.86 (1.83-4.47)	< .001
Protocol, 2000 versus 1992	0.90 (0.55-1.48)	.68		.32‡

CI indicates confidence interval.

Low-risk patients were excluded from the model because no T-ALL were assigned to low-risk therapy.

If only relapse was considered as an event, then P = .13.

P value of covariate if included in the final model.